Below, a list of constituents for BMED (BlackRock Future Health ETF) is shown. In total, BMED consists of 149 securities.
Note: The data shown here is as of date Mar 31, 2024 (the latest that can be sourced directly from the fund provider).
Click here to go back to the full list of ETFs.
Ticker | Name | Sector | Asset Class | Market Value | Weight (%) |
XTSLA | BLK CSH FND TREASURY SL AGENCY | Cash and/or Derivatives | Money Market | 180000.0 | 4.57 |
BSX | BOSTON SCIENTIFIC CORP | Health Care | Equity | 137435.35 | 3.49 |
COR | CENCORA INC | Health Care | Equity | 132300.2 | 3.36 |
ISRG | INTUITIVE SURGICAL INC | Health Care | Equity | 91127.43 | 2.31 |
WST | WEST PHARMACEUTICAL SERVICES INC | Health Care | Equity | 90646.55 | 2.3 |
ALGN | ALIGN TECHNOLOGY INC | Health Care | Equity | 90054.86 | 2.28 |
COO | COOPER INC | Health Care | Equity | 83344.8 | 2.11 |
BMRN | BIOMARIN PHARMACEUTICAL INC | Health Care | Equity | 77793.6 | 1.97 |
AMGN | AMGEN INC | Health Care | Equity | 76169.79 | 1.93 |
MASI | MASIMO CORP | Health Care | Equity | 67688.16 | 1.72 |
DHR | DANAHER CORP | Health Care | Equity | 63604.14 | 1.61 |
QGEN | QIAGEN NV | Health Care | Equity | 63193.44 | 1.6 |
ALNY | ALNYLAM PHARMACEUTICALS INC | Health Care | Equity | 62696.8 | 1.59 |
MTD | METTLER TOLEDO INC | Health Care | Equity | 61768.5 | 1.57 |
BPMC | BLUEPRINT MEDICINES CORP | Health Care | Equity | 61537.42 | 1.56 |
SYK | STRYKER CORP | Health Care | Equity | 59959.3 | 1.52 |
EW | EDWARDS LIFESCIENCES CORP | Health Care | Equity | 59368.7 | 1.51 |
GXI | GERRESHEIMER AG | Health Care | Equity | 59284.62 | 1.5 |
WAT | WATERS CORP | Health Care | Equity | 58637.25 | 1.49 |
ABBV | ABBVIE INC | Health Care | Equity | 58226.6 | 1.48 |
UNH | UNITEDHEALTH GROUP INC | Health Care | Equity | 57988.7 | 1.47 |
NBIX | NEUROCRINE BIOSCIENCES INC | Health Care | Equity | 57394.61 | 1.46 |
CRL | CHARLES RIVER LABORATORIES INTERNA | Health Care | Equity | 56266.05 | 1.43 |
TECH | BIO TECHNE CORP | Health Care | Equity | 55262.4 | 1.4 |
MCK | MCKESSON CORP | Health Care | Equity | 55148.26 | 1.4 |
DXCM | DEXCOM INC | Health Care | Equity | 53493.56 | 1.36 |
MOH | MOLINA HEALTHCARE INC | Health Care | Equity | 53274.45 | 1.35 |
ARGX | ARGENX SE ADR | Health Care | Equity | 49875.0 | 1.27 |
MRK | MERCK & CO INC | Health Care | Equity | 43180.0 | 1.1 |
SWAV | SHOCKWAVE MEDICAL INC | Health Care | Equity | 43081.97 | 1.09 |
RYTM | RHYTHM PHARMACEUTICALS INC | Health Care | Equity | 42251.44 | 1.07 |
NOVO B | NOVO NORDISK CLASS B | Health Care | Equity | 42063.55 | 1.07 |
INSP | INSPIRE MEDICAL SYSTEMS INC | Health Care | Equity | 41920.01 | 1.06 |
BIIB | BIOGEN INC | Health Care | Equity | 41609.94 | 1.06 |
BDX | BECTON DICKINSON | Health Care | Equity | 40218.76 | 1.02 |
SRPT | SAREPTA THERAPEUTICS INC | Health Care | Equity | 40008.5 | 1.01 |
LLY | ELI LILLY | Health Care | Equity | 39538.8 | 1.0 |
ELV | ELEVANCE HEALTH INC | Health Care | Equity | 38428.56 | 0.97 |
IMCR | IMMUNOCORE HOLDINGS ADR PLC | Health Care | Equity | 37596.21 | 0.95 |
ELAN | ELANCO ANIMAL HEALTH INC | Health Care | Equity | 36868.7 | 0.94 |
LEGN | LEGEND BIOTECH ADR REP CORP | Health Care | Equity | 36768.38 | 0.93 |
XENE | XENON PHARMACEUTICALS INC | Health Care | Equity | 36616.5 | 0.93 |
PCVX | VAXCYTE INC | Health Care | Equity | 34793.1 | 0.88 |
MRUS | MERUS NV | Health Care | Equity | 33785.85 | 0.86 |
RGEN | REPLIGEN CORP | Health Care | Equity | 32900.56 | 0.83 |
TMO | THERMO FISHER SCIENTIFIC INC | Health Care | Equity | 31756.45 | 0.81 |
SRT3 | SARTORIUS PREF AG | Health Care | Equity | 31004.13 | 0.79 |
NUVL | NUVALENT INC CLASS A | Health Care | Equity | 29904.0 | 0.76 |
BRKR | BRUKER CORP | Health Care | Equity | 29756.4 | 0.75 |
AZN | ASTRAZENECA ADR REPRESENTING .5 PL | Health Care | Equity | 29192.0 | 0.74 |
UTHR | UNITED THERAPEUTICS CORP | Health Care | Equity | 29151.0 | 0.74 |
HOLX | HOLOGIC INC | Health Care | Equity | 29149.8 | 0.74 |
CTEC | CONVATEC GROUP PLC | Health Care | Equity | 28837.39 | 0.73 |
LONN | LONZA GROUP AG | Health Care | Equity | 28604.26 | 0.73 |
CNC | CENTENE CORP | Health Care | Equity | 28495.06 | 0.72 |
LH | LABORATORY CORPORATION OF AMERICA | Health Care | Equity | 27032.2 | 0.69 |
SNY | SANOFI ADR REPRESENTING SA | Health Care | Equity | 26567.7 | 0.67 |
VKTX | VIKING THERAPEUTICS INC | Health Care | Equity | 26028.0 | 0.66 |
PEN | PENUMBRA INC | Health Care | Equity | 25356.45 | 0.64 |
BGNE | BEIGENE ADS REPRESENTING LTD | Health Care | Equity | 24644.52 | 0.63 |
EXEL | EXELIXIS INC | Health Care | Equity | 23520.32 | 0.6 |
RVMD | REVOLUTION MEDICINES INC | Health Care | Equity | 23275.86 | 0.59 |
PTGX | PROTAGONIST THERAPEUTICS INC | Health Care | Equity | 20791.3 | 0.53 |
CTLT | CATALENT INC | Health Care | Equity | 20253.9 | 0.51 |
ZBH | ZIMMER BIOMET HOLDINGS INC | Health Care | Equity | 20235.39 | 0.51 |
ICLR | ICON PLC | Health Care | Equity | 20113.6 | 0.51 |
ROIV | ROIVANT SCIENCES LTD | Health Care | Equity | 19402.0 | 0.49 |
STE | STERIS | Health Care | Equity | 18860.4 | 0.48 |
VRTX | VERTEX PHARMACEUTICALS INC | Health Care | Equity | 17633.44 | 0.45 |
GMAB | GENMAB | Health Care | Equity | 16392.82 | 0.42 |
TCRX | TSCAN THERAPEUTICS INC | Health Care | Equity | 15822.72 | 0.4 |
ZEAL | ZEALAND PHARMA | Health Care | Equity | 15701.14 | 0.4 |
RCKT | ROCKET PHARMACEUTICALS INC | Health Care | Equity | 14981.42 | 0.38 |
ARVN | ARVINAS INC | Health Care | Equity | 14480.3 | 0.37 |
DNLI | DENALI THERAPEUTICS INC | Health Care | Equity | 14470.8 | 0.37 |
EXAS | EXACT SCIENCES CORP | Health Care | Equity | 14229.0 | 0.36 |
IONS | IONIS PHARMACEUTICALS INC | Health Care | Equity | 14178.3 | 0.36 |
EHC | ENCOMPASS HEALTH CORP | Health Care | Equity | 13993.2 | 0.35 |
CABA | CABALETTA BIO INC | Health Care | Equity | 13284.0 | 0.34 |
TXG | 10X GENOMICS INC CLASS A | Health Care | Equity | 13237.12 | 0.34 |
GH | GUARDANT HEALTH INC | Health Care | Equity | 13104.4 | 0.33 |
CNMD | CONMED CORP | Health Care | Equity | 13091.87 | 0.33 |
BCYC | BICYCLE THERAPEUTICS ADR PLC | Health Care | Equity | 12921.9 | 0.33 |
BEAM | BEAM THERAPEUTICS INC | Health Care | Equity | 12802.62 | 0.32 |
HALO | HALOZYME THERAPEUTICS INC | Health Care | Equity | 12635.76 | 0.32 |
INCY | INCYTE CORP | Health Care | Equity | 12417.6 | 0.32 |
STOK | STOKE THERAPEUTICS INC | Health Care | Equity | 11998.14 | 0.3 |
HLXB | HELIX ACQUISITION II CORP CLASS A | Financials | Equity | 11735.9 | 0.3 |
GPCR | STRUCTURE THERAPEUTICS ADR INC | Health Care | Equity | 11256.87 | 0.29 |
PTCT | PTC THERAPEUTICS INC | Health Care | Equity | 11193.24 | 0.28 |
NRIX | NURIX THERAPEUTICS INC | Health Care | Equity | 11178.75 | 0.28 |
BIO | BIO RAD LABORATORIES INC CLASS A | Health Care | Equity | 10571.98 | 0.27 |
RARE | ULTRAGENYX PHARMACEUTICAL INC | Health Care | Equity | 10538.64 | 0.27 |
NYXH | NYXOAH SA | Health Care | Equity | 10122.2 | 0.26 |
TARS | TARSUS PHARMACEUTICALS INC | Health Care | Equity | 9991.8 | 0.25 |
MLTX | MOONLAKE IMMUNOTHERAPEUTICS CLASS | Health Care | Equity | 9631.61 | 0.24 |
TNDM | TANDEM DIABETES CARE INC | Health Care | Equity | 9306.8 | 0.24 |
ALKS | ALKERMES | Health Care | Equity | 9145.15 | 0.23 |
INSM | INSMED INC | Health Care | Equity | 9033.5 | 0.23 |
BBIO | BRIDGEBIO PHARMA INC | Health Care | Equity | 8885.65 | 0.23 |
KROS | KEROS THERAPEUTICS INC | Health Care | Equity | 8885.92 | 0.23 |
GKOS | GLAUKOS CORP | Health Care | Equity | 8579.05 | 0.22 |
GLPG | GALAPAGOS ADR REPRESENTING NV | Health Care | Equity | 8515.92 | 0.22 |
BDTX | BLACK DIAMOND THERAPEUTICS INC | Health Care | Equity | 8490.68 | 0.22 |
BHVN | BIOHAVEN LTD | Health Care | Equity | 8479.68 | 0.22 |
TWST | TWIST BIOSCIENCE CORP | Health Care | Equity | 8056.5 | 0.2 |
ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | Health Care | Equity | 7986.08 | 0.2 |
USD | USD CASH | Cash and/or Derivatives | Cash | 7932.01 | 0.2 |
CGON | CG ONCOLOGY INC | Health Care | Equity | 7858.9 | 0.2 |
DYN | DYNE THERAPEUTICS INC | Health Care | Equity | 7843.72 | 0.2 |
SAGE | SAGE THERAPEUTICS INC | Health Care | Equity | 7350.0 | 0.19 |
FDMT | 4D MOLECULAR THERAPEUTICS INC | Health Care | Equity | 7250.75 | 0.18 |
AUTL | AUTOLUS THERAPEUTICS ADR PLC | Health Care | Equity | 6689.69 | 0.17 |
RDNT | RADNET INC | Health Care | Equity | 6327.1 | 0.16 |
SANA | SANA BIOTECHNOLOGY INC | Health Care | Equity | 5885.88 | 0.15 |
MGNX | MACROGENICS INC | Health Care | Equity | 5667.7 | 0.14 |
VYGR | VOYAGER THERAPEUTICS INC | Health Care | Equity | 5435.26 | 0.14 |
IMTX | IMMATICS NV | Health Care | Equity | 5389.65 | 0.14 |
GMAB | GENMAB SPONSORED ADR | Health Care | Equity | 5380.83 | 0.14 |
AXSM | AXSOME THERAPEUTICS INC | Health Care | Equity | 5337.75 | 0.14 |
APLS | APELLIS PHARMACEUTICALS INC | Health Care | Equity | 5192.72 | 0.13 |
RCUS | ARCUS BIOSCIENCES INC | Health Care | Equity | 5122.76 | 0.13 |
TNYA | TENAYA THERAPEUTICS INC | Health Care | Equity | 5115.84 | 0.13 |
NVCR | NOVOCURE LTD | Health Care | Equity | 4750.9 | 0.12 |
LUNG | PULMONX CORP | Health Care | Equity | 4579.68 | 0.12 |
SIBN | SI BONE INC | Health Care | Equity | 4524.0 | 0.11 |
MORF | MORPHIC HOLDING INC | Health Care | Equity | 4264.26 | 0.11 |
IOVA | IOVANCE BIOTHERAPEUTICS INC | Health Care | Equity | 3747.2 | 0.1 |
ARWR | ARROWHEAD PHARMACEUTICALS INC | Health Care | Equity | 3726.4 | 0.09 |
ACIU | AC IMMUNE SA | Health Care | Equity | 3649.8 | 0.09 |
SGMT | SAGIMET BIOSCIENCES INC SERIES A | Health Care | Equity | 3523.65 | 0.09 |
RGNX | REGENXBIO INC | Health Care | Equity | 3448.6 | 0.09 |
PRME | PRIME MEDICINE INC | Health Care | Equity | 3431.0 | 0.09 |
BMEA | BIOMEA FUSION INC | Health Care | Equity | 3144.84 | 0.08 |
MASS | 908 DEVICES | Information Technology | Equity | 2517.76 | 0.06 |
ATXS | ASTRIA THERAPEUTICS INC | Health Care | Equity | 2385.0 | 0.06 |
KYTX | KYVERNA THERAPEUTICS INC | Health Care | Equity | 2249.17 | 0.06 |
NUVB | NUVATION BIO INC CLASS A | Health Care | Equity | 1768.9 | 0.04 |
NMRA | NEUMORA THERAPEUTICS INC | Health Care | Equity | 1678.25 | 0.04 |
CVAC | CUREVAC NV | Health Care | Equity | 1646.56 | 0.04 |
GLUE | MONTE ROSA THERAPEUTICS INC | Health Care | Equity | 1258.1 | 0.03 |
LBPH | LONGBOARD PHARMACEUTICALS INC | Health Care | Equity | 1145.5 | 0.03 |
nan | ABIOMED CVRS Prvt | Health Care | Equity | 703.56 | 0.02 |
LXEO | LEXEO THERAPEUTICS INC | Health Care | Equity | 687.5 | 0.02 |
MRTX | MIRATI THERAPEUTICS INC | Health Care | Equity | 233.8 | 0.01 |
EUR | EUR CASH | Cash and/or Derivatives | Cash | 66.56 | 0.0 |
KRRBIO | KORRO BIO INC CVR | Health Care | Equity | 5.71 | 0.0 |
JPY | JPY/USD | Cash and/or Derivatives | Forwards | -3079.51 | -0.08 |
The content contained herein is owned or licensed by BlackRock and/or its third-party information providers and is protected by applicable copyrights, trademarks, service marks, and/or other intellectual property rights. Such content is solely for your personal, non-commercial use. Accordingly, you may not copy, distribute, modify, post, frame or deep link this content. You may download material displayed on this Website for your personal use provided you also retain all copyright and other proprietary notices contained on the materials. Modification or use of the materials for any other purpose violates BlackRock's intellectual property rights. Holdings subject to change. See www.iShares.com for the most recent funds holdings. The values for “price” shown herein generally represent a price provided by a third-party pricing vendor for the portfolio holding and do not reflect the impact of systematic fair valuation (“the vendor price”). The vendor price is not necessarily the price at which the Fund values the portfolio holding for the purposes of determining its net asset value (the “valuation price”). Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U.S. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p.m. London. The values shown herein for “market value,” “weight,” and “notional value” (the “calculated values”) are based off of the vendor price and may have been different if the valuation price were to have been used to calculate such values. The vendor price is as of the most recent practicable date and may not necessarily be as of the date shown above. Please see the “Determination of Net Asset Value” section of each Fund’s prospectus for additional information on the Fund’s valuation policies and procedures. CAREFULLY CONSIDER THE FUNDS' INVESTMENT OBJECTIVES, RISK FACTORS, AND CHARGES AND EXPENSES BEFORE INVESTING. THIS AND OTHER INFORMATION CAN BE FOUND IN THE FUNDS' PROSPECTUSES OR, IF AVAILABLE, THE SUMMARY PROSPECTUSES WHICH MAY BE OBTAINED BY VISITING WWW.ISHARES.COM OR WWW.BLACKROCK.COM. READ THE PROSPECTUS CAREFULLY BEFORE INVESTING. INVESTING INVOLVES RISK, INCLUDING POSSIBLE LOSS OF PRINCIPAL. This information should not be relied upon as research, investment advice, or a recommendation regarding any products, strategies, or any security in particular. This material is strictly for illustrative, educational, or informational purposes and is subject to change. The Funds are distributed by BlackRock Investments, LLC (together with its affiliates, “BlackRock”). The iShares Funds are not sponsored, endorsed, issued, sold or promoted by Bloomberg, BlackRock Index Services, LLC, Cboe Global Indices, LLC, Cohen & Steers, European Public Real Estate Association (“EPRA® ”), FTSE International Limited (“FTSE”), ICE Data Indices, LLC, NSE Indices Ltd, JPMorgan, JPX Group, London Stock Exchange Group (“LSEG”), MSCI Inc., Markit Indices Limited, Morningstar, Inc., Nasdaq, Inc., National Association of Real Estate Investment Trusts (“NAREIT”), Nikkei, Inc., Russell, S&P Dow Jones Indices LLC or STOXX Ltd. None of these companies make any representation regarding the advisability of investing in the Funds. With the exception of BlackRock Index Services, LLC, who is an affiliate, BlackRock Investments, LLC is not affiliated with the companies listed above. Neither FTSE, LSEG, nor NAREIT makes any warranty regarding the FTSE Nareit Equity REITS Index, FTSE Nareit All Residential Capped Index or FTSE Nareit All Mortgage Capped Index. Neither FTSE, EPRA, LSEG, nor NAREIT makes any warranty regarding the FTSE EPRA Nareit Developed ex-U.S. Index, FTSE EPRA Nareit Developed Green Target Index or FTSE EPRA Nareit Global REITs Index. “FTSE®” is a trademark of London Stock Exchange Group companies and is used by FTSE under license. ©2023 BlackRock, Inc or its affiliates. All rights reserved. iSHARES, iBONDS and BLACKROCK are trademarks of BlackRock, Inc. or its affiliates. All other trademarks are those of their respective owners. iCRMH0323U/S-2742939 | nan | nan | nan | nan | nan |